BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 15495215)

  • 1. Wiskott-Aldrich syndrome protein and the cytoskeletal dynamics of dendritic cells.
    Calle Y; Chou HC; Thrasher AJ; Jones GE
    J Pathol; 2004 Nov; 204(4):460-9. PubMed ID: 15495215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wiskott-Aldrich syndrome: a disorder of haematopoietic cytoskeletal regulation.
    Thrasher AJ; Burns S
    Microsc Res Tech; 1999 Oct; 47(2):107-13. PubMed ID: 10523789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maturation of DC is associated with changes in motile characteristics and adherence.
    Burns S; Hardy SJ; Buddle J; Yong KL; Jones GE; Thrasher AJ
    Cell Motil Cytoskeleton; 2004 Feb; 57(2):118-32. PubMed ID: 14691951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linked regulation of motility and integrin function in activated migrating neutrophils revealed by interference in remodelling of the cytoskeleton.
    Anderson SI; Behrendt B; Machesky LM; Insall RH; Nash GB
    Cell Motil Cytoskeleton; 2003 Feb; 54(2):135-46. PubMed ID: 12529859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. WASp in immune-system organization and function.
    Thrasher AJ
    Nat Rev Immunol; 2002 Sep; 2(9):635-46. PubMed ID: 12209132
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of WASP/Scar proteins with actin and vertebrate Arp2/3 complex.
    Marchand JB; Kaiser DA; Pollard TD; Higgs HN
    Nat Cell Biol; 2001 Jan; 3(1):76-82. PubMed ID: 11146629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A partial down-regulation of WASP is sufficient to inhibit podosome formation in dendritic cells.
    Olivier A; Jeanson-Leh L; Bouma G; Compagno D; Blondeau J; Seye K; Charrier S; Burns S; Thrasher AJ; Danos O; Vainchenker W; Galy A
    Mol Ther; 2006 Apr; 13(4):729-37. PubMed ID: 16360341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The pleckstrin homology domain of the Wiskott-Aldrich syndrome protein is involved in the organization of actin cytoskeleton.
    Imai K; Nonoyama S; Miki H; Morio T; Fukami K; Zhu Q; Aruffo A; Ochs HD; Yata J; Takenawa T
    Clin Immunol; 1999 Aug; 92(2):128-37. PubMed ID: 10444357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Essential role of neural Wiskott-Aldrich syndrome protein in podosome formation and degradation of extracellular matrix in src-transformed fibroblasts.
    Mizutani K; Miki H; He H; Maruta H; Takenawa T
    Cancer Res; 2002 Feb; 62(3):669-74. PubMed ID: 11830518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A lentiviral vector encoding the human Wiskott-Aldrich syndrome protein corrects immune and cytoskeletal defects in WASP knockout mice.
    Charrier S; Stockholm D; Seye K; Opolon P; Taveau M; Gross DA; Bucher-Laurent S; Delenda C; Vainchenker W; Danos O; Galy A
    Gene Ther; 2005 Apr; 12(7):597-606. PubMed ID: 15616597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatial and temporal regulation of actin polymerization for cytoskeleton formation through Arp2/3 complex and WASP/WAVE proteins.
    Suetsugu S; Miki H; Takenawa T
    Cell Motil Cytoskeleton; 2002 Mar; 51(3):113-22. PubMed ID: 11921168
    [No Abstract]   [Full Text] [Related]  

  • 12. Regulation of cancer cell motility through actin reorganization.
    Yamazaki D; Kurisu S; Takenawa T
    Cancer Sci; 2005 Jul; 96(7):379-86. PubMed ID: 16053508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hematopoietic lineage cell-specific protein 1 functions in concert with the Wiskott-Aldrich syndrome protein to promote podosome array organization and chemotaxis in dendritic cells.
    Dehring DA; Clarke F; Ricart BG; Huang Y; Gomez TS; Williamson EK; Hammer DA; Billadeau DD; Argon Y; Burkhardt JK
    J Immunol; 2011 Apr; 186(8):4805-18. PubMed ID: 21398607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of the Wiskott-Aldrich syndrome protein and other actin regulatory adaptors in T cell activation.
    Badour K; Zhang J; Siminovitch KA
    Semin Immunol; 2004 Dec; 16(6):395-407. PubMed ID: 15541654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel membrane cell projection defects in Wiskott-Aldrich syndrome B cells.
    Andreu N; Aran JM; Fillat C
    Int J Mol Med; 2007 Oct; 20(4):445-50. PubMed ID: 17786274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of WASP and Scar1/WAVE1 actin-associated proteins is differentially modulated during differentiation of HL-60 cells.
    Launay S; Brown G; Machesky LM
    Cell Motil Cytoskeleton; 2003 Apr; 54(4):274-85. PubMed ID: 12601690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WIP and WASP play complementary roles in T cell homing and chemotaxis to SDF-1alpha.
    Gallego MD; de la Fuente MA; Anton IM; Snapper S; Fuhlbrigge R; Geha RS
    Int Immunol; 2006 Feb; 18(2):221-32. PubMed ID: 16141245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Wiskott-Aldrich syndrome protein (WASP): roles in signaling and cytoskeletal organization.
    Snapper SB; Rosen FS
    Annu Rev Immunol; 1999; 17():905-29. PubMed ID: 10358777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for a complex of Wiskott-Aldrich syndrome protein (WASP) with WASP interacting protein in podosome formation in macrophages.
    Tsuboi S
    J Immunol; 2007 Mar; 178(5):2987-95. PubMed ID: 17312144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Wiskott-Aldrich syndrome: disordered actin dynamics in haematopoietic cells.
    Thrasher AJ; Burns S; Lorenzi R; Jones GE
    Immunol Rev; 2000 Dec; 178():118-28. PubMed ID: 11213796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.